5results about How to "Suppress instability" patented technology

This invention discloses a digital isolator circuit with additional delay, including a transmitter circuit that receives a data input signal and generates first and second transmitter output signals, wherein the second transmitter output signal is a delayed version of the first transmitter output signal. Subsequently, an isolation barrier generates the first and second isolation output signals, causing a receiver circuit to generate a data output signal in response to these isolation output signals. By further incorporating a delay circuit in the transmitter circuit to delay the first transmitter output signal and generate the second transmitter output signal, this invention effectively enhances the received signal at the receiver circuit, maintaining the stability of the common-mode signal and the robustness of data transmission. A pulse carrier modulation mechanism is also employed to effectively reduce power consumption, electromagnetic interference, and signal jitter.

The invention relates to the field of lithium iron phosphate, in particular to a composite solid electrolyte synergistically modified lithium iron phosphate positive electrode material and a preparation method thereof. The preparation method is used for solving the problems that existing lithium iron phosphate is poor in electronic conductivity, high in interface impedance and poor and low in interface stability. The lithium iron phosphate positive electrode material synergistically modified by the composite solid electrolyte comprises COF / neodymium-doped lithium titanium aluminum phosphate modified lithium iron phosphate, acetylene carbon black, polyethylene glycol and N-methyl pyrrolidone, according to the preparation method, firstly, lithium iron phosphate is prepared, neodymium ions are doped in the process of preparing lithium titanium aluminum phosphate to serve as a first modification layer, cyanophenothiazine COF is synthesized to serve as a second modification layer, two layers of solid electrolyte are modified on the surface of the lithium iron phosphate to achieve a synergistic effect to form a protective film, and formation of lithium dendrites can be effectively reduced; the interface stability and the cycle performance of the material are remarkably improved, and the safety of the battery is enhanced.

The present application relates to the technical field of controllable nuclear fusion, and particularly relates to a device for controlling energy confinement time by using a limiter bias system. The device comprises a bias electrode head, a soft connection wire connected with the bias electrode head at one end and connected with a bias power supply system of an NCST spherical tokamak device at the other end, and a limiter main body installed on one side of the NCST spherical tokamak device and provided with the bias electrode head for restraining the escaped electrons generated by discharge of the NCST spherical tokamak device. The present application can restrain the escaped electrons generated by discharge of the NCST spherical tokamak device by installing the limiter bias system, improve the energy confinement time parameter of the NCST spherical tokamak device, significantly restrain the plasma instability, and thus increase the plasma current duration and improve the plasma current size.

This invention discloses the application of an inhibitor of the BEX4-XRCC5 interaction in the preparation of an anti-hepatoblastoma drug, belonging to the field of biomedical technology. The inhibitor, F35-303, specifically disrupts the direct interaction between BEX4 and XRCC5 proteins, inhibiting the DNA non-homologous end joining repair pathway, thereby targeting hepatoblastoma tumor stem cells and overcoming the limitations of existing therapies. It is particularly suitable for treating platinum-resistant or recurrent hepatoblastoma. The inhibitor is a small molecule compound named F35-303. This invention also provides pharmaceutical compositions containing this inhibitor and their combination therapy with platinum-based chemotherapy drugs (such as cisplatin), which can synergistically enhance efficacy and reduce toxic side effects. This invention provides a novel targeted therapy strategy for hepatoblastoma.

The application provides a parameter extraction and alignment processing method and system for DLCP test data, which comprises the following steps: DLCP tests are carried out at multiple different test frequencies to obtain the capacitance bias curve data corresponding to each test frequency; the validity of the capacitance bias curve data is determined, and each curve data determined as valid is subjected to function fitting, and the capacitance parameters corresponding to each test frequency are extracted from the fitting results; based on the capacitance parameters, the spatial position parameters corresponding to each test frequency are calculated through a first model; the spatial position parameters corresponding to a preset high frequency are taken as a reference for alignment processing, and a multi-frequency data set in a unified depletion region width coordinate system is output; the trap density distribution is obtained by performing multi-frequency capacitance data difference calculation, and trap density spatial distribution data is output. Through the spatial alignment processing of the capacitance bias data at different test frequencies based on a unified physical model, the accuracy and stability of the test results are improved.